BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34970871)

  • 1. Network-Based Approaches for Drug Repositioning.
    Song T; Wang G; Ding M; Rodriguez-Paton A; Wang X; Wang S
    Mol Inform; 2022 May; 41(5):e2100200. PubMed ID: 34970871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Drug Repositioning Approach Based on Integrative Multiple Similarity Measures.
    Yan C; Feng L; Wang W; Wang J; Zhang G; Luo J
    Curr Mol Med; 2020; 20(6):442-451. PubMed ID: 31729291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repositioning by integrating target information through a heterogeneous network model.
    Wang W; Yang S; Zhang X; Li J
    Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity.
    Lei S; Lei X; Chen M; Pan Y
    Interdiscip Sci; 2024 Mar; 16(1):160-175. PubMed ID: 38103130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedical data and computational models for drug repositioning: a comprehensive review.
    Luo H; Li M; Yang M; Wu FX; Li Y; Wang J
    Brief Bioinform; 2021 Mar; 22(2):1604-1619. PubMed ID: 32043521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning.
    Yang K; Yang Y; Fan S; Xia J; Zheng Q; Dong X; Liu J; Liu Q; Lei L; Zhang Y; Li B; Gao Z; Zhang R; Liu B; Wang Z; Zhou X
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36562715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid attentional memory network for computational drug repositioning.
    He J; Yang X; Gong Z; Zamit L
    BMC Bioinformatics; 2020 Dec; 21(1):566. PubMed ID: 33297947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heter-LP: A Heterogeneous Label Propagation Method for Drug Repositioning.
    Lotfi Shahreza M; Ghadiri N; Green JR
    Methods Mol Biol; 2019; 1903():291-316. PubMed ID: 30547450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
    Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
    Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A geometric deep learning framework for drug repositioning over heterogeneous information networks.
    Zhao BW; Su XR; Hu PW; Ma YP; Zhou X; Hu L
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36125202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning in target prediction and drug repositioning: Recent advances and challenges.
    Yu JL; Dai QQ; Li GB
    Drug Discov Today; 2022 Jul; 27(7):1796-1814. PubMed ID: 34718208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.